Peptable

Comparison

Hexarelin vs KPV

Also see:

HexarelinKPV

Function

While Hexarelin is investigated for effects on GH secretion, cardiac protection, and muscle metabolism, with higher GH secretory potency than earlier GHRPs1929, KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684.

Mechanism

While Hexarelin works as a potent synthetic hexapeptide (examorelin) that agonizes GHSR-1a to stimulate GH release and also binds CD36, influencing cardiovascular and metabolic pathways19212996, KPV is the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684.

Receptor

Hexarelin

Primary: GHSR-1a (ghrelin receptor); also binds the scavenger receptor CD36 in vascular and macrophage tissues192129

KPV

No single primary receptor; the KPV motif can influence melanocortin receptor binding profiles (MC1R–MC5R), but many anti-inflammatory effects appear melanocortin-independent684

Organism or Origin

Hexarelin

Fully synthetic growth hormone secretagogue29

KPV

Endogenous tripeptide corresponding to positions 11–13 of human α-MSH8490

Gene

Hexarelin

GHSR

KPV

POMC

Summary

Hexarelin and KPV are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Hexarelin is more often discussed in the realm of Metabolic and endocrine and Cardiovascular health, whereas KPV is more often associated with the realm of Immunology and inflammation, Gastroenterology, and Dermatology and aesthetics. They also influence different molecular systems, with Hexarelin tracking more closely to Ghrelin receptor while KPV centers more on Melanocortin receptor. Hexarelin has a more synthetic design origin, while KPV is closer to natural endogenous background and both are still best understood as being in Preclinical development. Hexarelin incorporates d-amino acid substitution and amidation features that are not part of KPV.

Related articles

No related articles are linked to these peptides yet.

Sources

19Identification of the growth hormone-releasing peptide binding site ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC1133797/
21Hexarelin Peptide | Strength & Recovery - Paragon Sports Medicine, https://www.paragonsportsmedicine.com/peptides/hexarelin
29Examorelin - Wikipedia, https://en.wikipedia.org/wiki/Examorelin
96Growth Hormone Secretagogue Receptor - ScienceDirect.com, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/growth-hormone-secretagogue-receptor
6Keratinocyte And Dermal..., https://oathresearch.com/2026/03/27/kpv-tripeptide-nfkb-inhibition-anti-inflammatory-mechanisms-cell-culture/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/